Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Forbion Ventures Fund Vi Coã¶Peratief U.A. investment portfolio

Forbion Ventures Fund Vi Coã¶Peratief U.A. has made numerous investments in companies such as Verdiva Bio, Purespring Therapeutics, and Loqus23 Therapeutics within the Biotech sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorSourceLast confirmed on
Loqus23 Therapeutics Limited
LOQUS23 THERAPEUTICS LIMITED is a biotechnology company that develops small molecule somatic expansion inhibitors to treat Huntington's Disease and other triplet repeat expansion diseases. The company's lead product candidate, LQT-23, is an oral small molecule MSH3/MutSβ inhibitor designed to slow or halt the progression of these neurodegenerative disorders.
BiotechHealth Tech
Confirmed2026-03-28
Purespring Therapeutics LimitedHealthcare & Life SciencesConfirmed2026-03-31

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (3)

Forbion Ventures Fund Vi Coã¶Peratief U.A.'s positions across portfolio companies
2026
2025

Sign up free to see when this investor has bought or sold shares.

+1 more change

Sign up

Articles (1)